Inotrem Receives Funding From The Crohn’s & Colitis Foundation To Help Develop New Therapeutic Approaches In Inflammatory Bowel Disease (Ibd)
Round Type
Funding Round
ParisBiotechnologyHealth CareTherapeuticsInvestors
Description
Inotrem, an advanced clinical stage biotech company specialized in immunotherapies for acute and chronic inflammatory syndromes, announced today it received funding from the Crohn’s & Colitis Foundation’s IBD Ventures under a program to accelerate research and development that aim to improve the quality of life for patients with IBD. The funding will support the development of a new therapeutic approach in IBD focusing on the TREM-1 pathway.
Quick answer
Inotrem raised an undisclosed amount in a Funding Round round, dated January 9, 2023. Investors: Crohn’s & Colitis Foundation’s IBD Ventures. Inotrem is based in Paris, Ile-de-France, France.
- How much did Inotrem raise?
- Inotrem raised an undisclosed amount in a Funding Round round on January 9, 2023.
- Who invested in Inotrem?
- Crohn’s & Colitis Foundation’s IBD Ventures is named as investors in this round.
- What does Inotrem do?
- Inotrem S.A. is an advanced clinical stage biotech company specialized in immunotherapies for acute and chronic inflammatory syndromes.
- Where is Inotrem based and how big is it?
- Inotrem is based in Paris, Ile-de-France, France.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Inotrem that raised within 45 days of this round, from Fundz verified event records.
- Transcend Therapeutics raised an undisclosed amount (Series A) on February 23, 2023.
- Voyager Therapeutics raised $39M on February 23, 2023.
- Azora Therapeutics, Inc. (DE) raised $62K (Pre-Seed) on February 23, 2023.
- Current Surgical raised $3.2M (Seed) on February 21, 2023.
- Pathos AI raised $20M on February 17, 2023.
- Alpha Cognition raised $1.8M (Seed) on February 16, 2023.
Who to call at Inotrem, and when
A new round usually means Inotrem is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Inotrem raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Inotrem, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Inotrem. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Inotrem raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Inotrem raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.